LeonaBio, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
LeonaBio, Inc. (LONA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 37.67 million shares for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-08-15
- LeonaBio, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-06-30 was 37.67M shares, a 1.22% increase year-over-year.
- LeonaBio, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 37.59M shares, a 5.08% increase year-over-year.
- LeonaBio, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 37.37M shares, a 15.32% increase year-over-year.
- LeonaBio, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 37.31M shares, a 393.25% increase year-over-year.
- LeonaBio, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 36.92M shares, a 208.53% increase from fiscal 2020.
- LeonaBio, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 11.97M shares, a 235.50% increase from fiscal 2019.
- LeonaBio, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 3.57M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2022-06-30 | 37.67M shares 10-Q · filed 2022-08-15 | 37.63M shares 10-Q · filed 2022-08-15 | 37.54M shares derived: average of 3 quarters · filed 2022-08-15 | 37.48M shares derived: average of 4 quarters · filed 2022-08-15 | ||
| 2022-03-31 | 37.59M shares 10-Q · filed 2022-05-12 | 37.48M shares derived: average of 2 quarters · filed 2022-05-12 | 37.42M shares derived: average of 3 quarters · filed 2022-05-12 | 37.37M shares derived: average of 4 quarters · filed 2022-08-15 | ||
| 2021-12-31 | 37.37M shares derived: 10-K 12 month − 10-K 9 month · filed 2022-03-28 | 37.34M shares derived: average of 2 quarters · filed 2022-03-28 | 37.30M shares derived: average of 3 quarters · filed 2022-08-15 | 36.92M shares 10-K · filed 2022-03-28 | ||
| 2021-09-30 | 37.31M shares 10-Q · filed 2021-11-10 | 37.26M shares derived: average of 2 quarters · filed 2022-08-15 | 36.77M shares 10-K · filed 2022-03-28 | 34.32M shares 10-Q · filed 2021-11-10 | 35.68M shares derived: average of 4 quarters · filed 2022-08-15 | |
| 2021-06-30 | 37.21M shares 10-Q · filed 2022-08-15 | 36.50M shares 10-Q · filed 2022-08-15 | 33.81M shares 10-Q · filed 2021-08-16 | 35.13M shares derived: average of 3 quarters · filed 2022-08-15 | 28.24M shares derived: average of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | 35.78M shares 10-Q · filed 2022-05-12 | 34.09M shares derived: average of 2 quarters · filed 2022-05-12 | 25.25M shares derived: average of 3 quarters · filed 2022-05-12 | 19.97M shares derived: average of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | 32.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 19.98M shares derived: average of 2 quarters · filed 2022-03-28 | 14.70M shares derived: average of 3 quarters · filed 2022-03-28 | 11.97M shares 10-K · filed 2022-03-28 | ||
| 2020-09-30 | 7.56M shares 10-Q · filed 2021-11-10 | 5.85M shares derived: average of 2 quarters · filed 2021-11-10 | 5.16M shares 10-Q · filed 2021-11-10 | 4.76M shares derived: average of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | 4.13M shares 10-Q · filed 2021-08-16 | 3.94M shares 10-Q · filed 2021-08-16 | 3.83M shares derived: average of 3 quarters · filed 2021-08-16 | 3.76M shares derived: average of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | 3.75M shares 10-Q · filed 2021-05-13 | 3.68M shares derived: average of 2 quarters · filed 2021-05-13 | 3.64M shares derived: average of 3 quarters · filed 2021-05-13 | |||
| 2019-12-31 | 3.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 3.58M shares derived: average of 2 quarters · filed 2021-03-25 | 3.57M shares 10-K · filed 2021-03-25 | |||
| 2019-09-30 | 3.55M shares 10-Q · filed 2020-11-12 | 3.55M shares 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |